Atlas Arteria
Market Cap
AU$4.5b
Last Updated
2020/04/07 10:43 UTC
Data Sources
Company Financials +
Executive Summary
Atlas Arteria Limited owns, develops, and operates toll roads.
Rewards
Risk Analysis
+ 1 more risk
Snowflake Analysis
Moderate growth potential and slightly overvalued.
Similar Companies
Share Price & News
How has Atlas Arteria's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ALX's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-4.7%
ALX
-8.7%
AU Infrastructure
2.8%
AU Market
1 Year Return
-24.8%
ALX
-17.7%
AU Infrastructure
-16.2%
AU Market
Return vs Industry: ALX underperformed the Australian Infrastructure industry which returned -17.9% over the past year.
Return vs Market: ALX underperformed the Australian Market which returned -19.2% over the past year.
Shareholder returns
| ALX | Industry | Market | |
|---|---|---|---|
| 7 Day | -4.7% | -8.7% | 2.8% |
| 30 Day | -31.4% | -26.7% | -15.2% |
| 90 Day | -34.4% | -28.6% | -23.4% |
| 1 Year | -22.1%-24.8% | -14.6%-17.7% | -12.4%-16.2% |
| 3 Year | 14.9%1.7% | 7.1%-6.7% | -0.2%-13.9% |
| 5 Year | 84.9%50.4% | 39.6%11.7% | 11.5%-13.6% |
Price Volatility Vs. Market
How volatile is Atlas Arteria's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
Graeme Bevans Is The MD, CEO & Director of Atlas Arteria Limited (ASX:ALX) And They Just Spent AU$58k On Shares1 month ago | Simply Wall St
Would Atlas Arteria (ASX:ALX) Be Better Off With Less Debt?2 months ago | Simply Wall St
Should You Buy Atlas Arteria Limited (ASX:ALX) For Its Dividend?Valuation
Is Atlas Arteria undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ALX (A$5) is trading below our estimate of fair value (A$33.6)
Significantly Below Fair Value: ALX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ALX is poor value based on its PE Ratio (204.4x) compared to the Infrastructure industry average (31.6x).
PE vs Market: ALX is poor value based on its PE Ratio (204.4x) compared to the Australian market (13x).
Price to Earnings Growth Ratio
PEG Ratio: ALX is poor value based on its PEG Ratio (3.9x)
Price to Book Ratio
PB vs Industry: ALX is overvalued based on its PB Ratio (1.3x) compared to the AU Infrastructure industry average (1.2x).
Next Steps
Future Growth
How is Atlas Arteria forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
52.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALX's forecast earnings growth (52.5% per year) is above the savings rate (1.1%).
Earnings vs Market: ALX's earnings (52.5% per year) are forecast to grow faster than the Australian market (10.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ALX's revenue (3.3% per year) is forecast to grow slower than the Australian market (4.1% per year).
High Growth Revenue: ALX's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALX's Return on Equity is forecast to be low in 3 years time (15.6%).
Next Steps
Past Performance
How has Atlas Arteria performed over the past 5 years?
3.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ALX has a large one-off loss of A$66.0M impacting its December 31 2019 financial results.
Growing Profit Margin: ALX's current net profit margins (9.7%) are lower than last year (57.9%).
Past Earnings Growth Analysis
Earnings Trend: ALX has become profitable over the past 5 years, growing earnings by 3.3% per year.
Accelerating Growth: ALX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ALX had negative earnings growth (-77.7%) over the past year, making it difficult to compare to the Infrastructure industry average (-14.8%).
Return on Equity
High ROE: ALX's Return on Equity (-0.3%) is considered low.
Next Steps
Financial Health
How is Atlas Arteria's financial position?
Financial Position Analysis
Short Term Liabilities: ALX's short term assets (A$1.6B) exceed its short term liabilities (A$104.9M).
Long Term Liabilities: ALX's short term assets (A$1.6B) do not cover its long term liabilities (A$2.2B).
Debt to Equity History and Analysis
Debt Level: ALX's debt to equity ratio (64.4%) is considered high.
Reducing Debt: Insufficient data to determine if ALX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ALX's debt is not well covered by operating cash flow (3.5%).
Interest Coverage: Insufficient data to determine if ALX's interest payments on its debt are well covered by EBIT.
Balance Sheet
Next Steps
Dividend
What is Atlas Arteria's current dividend yield, its reliability and sustainability?
6.24%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ALX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ALX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ALX is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ALX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.0yrs
Average management tenure
CEO
Graeme Bevans (61yo)
1
Tenure
AU$2,747,183
Compensation
Mr. Graeme Francis Bevans serves as Managing Director, Chief Executive Officer and Director at Atlas Arteria Limited since April 1, 2019. Mr. Bevans was a Partner at Alinda Capital Partners LLC since 2010. ...
CEO Compensation Analysis
Compensation vs Market: Graeme's total compensation ($USD1.65M) is below average for companies of similar size in the Australian market ($USD2.52M).
Compensation vs Earnings: Graeme's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 1yr | AU$2.75m | 0.011% A$514.8k | |
| Chief Financial Officer | 1yr | AU$1.15m | 0.0024% A$106.0k | |
| Chief Operating Officer | 1yr | AU$1.10m | 0.00064% A$28.7k | |
| Head of Investor Relations | no data | no data | no data | |
| Company Secretary & General Counsel | 1yr | no data | no data | |
| Public Affairs Manager | no data | no data | no data |
1.0yrs
Average Tenure
Experienced Management: ALX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 1yr | AU$2.75m | 0.011% A$514.8k | |
| Independent Non-Executive Chairman | 5yrs | AU$290.00k | 0.012% A$530.5k | |
| Independent Non-Executive Director | 1.42yrs | AU$185.00k | 0.0029% A$128.9k | |
| Independent Non Executive Director | 1.5yrs | AU$187.50k | 0.0023% A$104.7k | |
| Independent Non-Executive Director | 2.58yrs | AU$207.50k | 0.0032% A$143.3k |
1.5yrs
Average Tenure
59yo
Average Age
Experienced Board: ALX's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ALX insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.
Top Shareholders
Company Information
Atlas Arteria Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Atlas Arteria Limited
- Ticker: ALX
- Exchange: ASX
- Founded: 2009
- Industry: Highways and Railtracks
- Sector: Transportation
- Market Cap: AU$4.492b
- Shares outstanding: 879.02m
- Website: https://www.atlasarteria.com
Location
- Atlas Arteria Limited
- 141 Flinders Lane
- Level 5
- Melbourne
- Victoria
- 3000
- Australia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ALX | ASX (Australian Securities Exchange) | Yes | Stapled Securities | AU | AUD | Jan 2010 |
| M82 | DB (Deutsche Boerse AG) | Yes | Stapled Securities | DE | EUR | Jan 2010 |
| MAQA.F | OTCPK (Pink Sheets LLC) | Yes | Stapled Securities | US | USD | Jan 2010 |
| ALX | CHIA (Chi-X Australia) | Yes | Stapled Securities | AU | AUD | Jan 2010 |
Biography
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/04/07 10:43 |
| End of Day Share Price | 2020/04/07 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.